Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Agilent Technologies Inc.. (4/26/18). "Press Release: Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing". Santa Clara, CA.

Organisation Organisation Dako (Group)
Product Product  Dako Omnis staining platform
Persons Person Heimburger, Jeff (Agilent 201804 Head of Marketing of Genomics Division)
  Person 2 Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations)
     


Fully automated CISH and IQFISH panel for lymphoma combines multiple innovations


Agilent Technologies Inc. (NYSE: A) today announced an expansion of its portfolio of in situ hybridization probes with the release of its EBER RNA CISH, Kappa, and Lambda mRNA CISH probes for Dako Omnis. A manual IQFISH panel for lymphoma was also announced which will carry CE-marking for in vitro diagnostics in Europe.

The EBER RNA CISH, Kappa, and Lambda mRNA CISH product release further increase the diagnostic capabilities of the Dako Omnis instrumentation, which can now be used to simultaneously run tests involving chromogenic in situ hybridization (CISH), fluorescence in situ hybridization (FISH), and immunohistochemistry (IHC). Coupled with fully optimized and validated protocols, the Dako Omnis enables fast turnaround times of patient cases and supports labs in delivering consistent quality and optimal results.

"Running CISH simultaneously with IHC on the Dako Omnis is a perfect solution for our lab and saves a great deal of hands-on time," said Dorthe Strue-Nielsen, medical laboratory technologist at Sjælland University Hospital, Pathology Division-Næstved, in Denmark.

The IQFISH panel for lymphoma is a set of oligonucleotide-based FISH probes designed to detect rearrangements involving the MYC, BCL2, BCL6, MALT1, CCND1, and IGH genes. These probes are for use on formalin-fixed, paraffin-embedded tissue sections and are available in break-apart and dual-fusion methodologies.

The probes are produced using synthetic oligonucleotides rather than the more common bacterial artificial chromosomes. This innovative technology eliminates repetitive sequences from the probes, which can decrease signal background.

"CISH probes are manufactured with Agilent's unique process. Simultaneously running them as part of the FISH and IHC workflow on Dako Omnis increases lab productivity, which can enable faster diagnosis for the patient" said Jeff Heimburger, head of marketing at Agilent's Genomics Division.

Agilent was the first commercial vendor to bring fast hybridization technology to pathology labs. Agilent's IQFISH Buffer improves hybridization kinetics, so tests that would normally take two days can now be completed in less than 5 hours. For most laboratories, this innovation means that FISH testing can be done each time a pathologist makes a request, getting the results to the patient sooner.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com.


Contact

Victoria Wadsworth-Hansen
Agilent Technologies
+1 408 553 2005
+45 29 33 69 80
victoria.wadsworth-hansen@agilent.com

   
Record changed: 2018-05-02

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px




» top